DNA Is Not Destiny: The Future of Personalized Menopause Care

29 Jul 2026 · 60 min
Menopause Mastery

29 Jul 2026 · 60 min

0:00

Dr. Betty Murray and Tracy Woods, CEO of The DNA Company, discuss how genetic testing can personalize menopause care beyond standard treatments. Woods shares how her company's DNA 360 test identifies variants like COMT and CYP2C9 to guide decisions on hormone therapy, GLP-1 drugs, and diet, and describes her own remission from MS after applying genetic insights.

Chapters

More from Dr.

46:44
Podcast

Histamine, Mold & Menopause: Why Your Symptoms Suddenly Change

1d ago
22:36
Podcast

Can Brain Retraining Help Perimenopause Symptoms? Inside a New Research Study

1w ago
54:49
Podcast

Glutathione, Menopause, & Aging: The Missing Piece in Oxidative Stress and Why It Matters

2w ago
38:31
Podcast

Why Stress Makes Menopause Symptoms Worse (and What to Do About It)

3w ago
25:09
Podcast

The Grief No One Talks About: Menopause, Caregiving & the Weight We Carry

4w ago
45:41
Podcast

Your Gut Is Talking to Your Hormones: The Menopause Microbiome Connection

1mo ago
34:03
Podcast

I Changed My Mind About GLP-1s: What You Need to Know About Ozempic, HRT, and Longevity

1mo ago
31:50
Podcast

6 New Menopause Studies Every Woman Should Know About

1mo ago
51:32
Podcast

Menopause and Genetics: Why Your DNA Test Might Be Missing the Real Story

1mo ago
34:50
Podcast

Beyond Hormones: The Cellular Health Secrets to Aging Wel

2mo ago
30:13
Podcast

Perimenopause vs. Menopause: What Most Women Never Get Told

2mo ago
See all content